Adaptive Sample Size Calculations in Group Sequential Trials
From MaRDI portal
(Redirected from Publication:4668352)
Recommendations
- Development of Adaptive Group Sequential Procedure for Changing Sample Size
- Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches
- scientific article; zbMATH DE number 3923914
- Modification of Sample Size in Group Sequential Clinical Trials
- Data-Driven Analysis Strategies for Proportion Studies in Adaptive Group Sequential Test Designs
Cites work
- A Comparison of Two Methods for Adaptive Interim Analyses in Clinical Trials
- A Two-Sample Test for a Linear Hypothesis Whose Power is Independent of the Variance
- Approximately Optimal One-Parameter Boundaries for Group Sequential Trials
- Designed Extension of Studies Based on Conditional Power
- Discrete Sequential Boundaries for Clinical Trials
- Evaluation of Experiments with Adaptive Interim Analyses
- Group Sequential Monitoring with Arbitrary Inspection Times
- scientific article; zbMATH DE number 4149427 (Why is no real title available?)
- On the Power of Fisher's Combination Test for Two Stage Sampling in the Presence of Nuisance Parameters
Cited in
(only showing first 100 items - show all)- Basic concepts of group sequential and adaptive group sequential test procedures
- Sequential monitoring of response-adaptive randomized clinical trials with sample size re-estimation
- Optimal two-stage group-sequential designs
- Trendtests with adaptive scoring.
- Adaptive modifications of hypotheses after an interim analysis
- Adaptive designs with arbitrary dependence structure
- A comparison of methods for constructing confidence intervals after phase II/III clinical trials
- Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications
- An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size
- Adaptive designs for subpopulation analysis optimizing utility functions
- Adaptive dose-finding: Proof of concept with type I error control
- Internal pilots for observational studies
- On sample size and inference for two-stage adaptive designs
- Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches
- Monitoring Clinical Trials with Multiple Arms
- A simple algorithm for designing group sequential clinical trials
- Self-designing two-stage trials to minimize expected costs
- P-value adjustment in sequential clinical trials
- Sequential tests for noninferiority and superiority
- Statistical inference in adaptive group sequential trials with the standardized mean difference as effect size
- An approach to the conditional error rate principle with nuisance parameters
- Sample size recalculation in sequential diagnostic trials
- Power, sample size and adaptation considerations in the design of group sequential clinical trials
- Adaptive Design for Censored Survival Data Adjusting for Covariates
- Are Flexible Designs Sound?
- Optimal Conditional Error Functions for the Control of Conditional Power
- Estimation of a Parameter and Its Exact Confidence Interval Following Sequential Sample Size Reestimation Trials
- Generalized Likelihood Ratio Statistics and Uncertainty Adjustments in Efficient Adaptive Design of Clinical Trials
- α-Investing: a Procedure for Sequential Control of Expected False Discoveries
- Development of Adaptive Group Sequential Procedure for Changing Sample Size
- Exact Confidence Bounds Following Adaptive Group Sequential Tests
- scientific article; zbMATH DE number 3923914 (Why is no real title available?)
- Group Sequential Monitoring with Arbitrary Inspection Times
- GROUP SEQUENTIAL TESTS WITH OUTCOME-DEPENDENT TREATMENT ASSIGNMENT
- Data-Driven Analysis Strategies for Proportion Studies in Adaptive Group Sequential Test Designs
- A MORE GENERAL CRITERION FOR SUBSET SELECTION IN MULTIPLE LINEAR REGRESSION
- Recursive Combination Tests
- Adapting sample size calculations to repeated measurements in clinical trials
- Improving the flexibility and efficiency of phase II designs for oncology trials
- Statistical Inference for Self‐Designing Clinical Trials with a One‐Sided Hypothesis
- Modification of Sample Size in Group Sequential Clinical Trials
- Interim Analysis and Sample Size Reassessment
- Procedure for determining sample size at each stage in group sequential test
- Interim design modifications in time-to-event studies
- Adaptive designs for noninferiority trials
- Confidence intervals for the selected population in randomized trials that adapt the population enrolled
- Partition testing in confirmatory adaptive designs with structured objectives
- Adaptive multivariate global testing
- SEAMLESS PHASE II/III CLINICAL TRIALS WITH COVARIATE ADAPTIVE RANDOMIZATION
- A note on the shape of sample size functions of optimal adaptive two-stage designs
- Interim analysis of sequential estimation-adjusted urn models with sample size re-estimation
- Sample size re-estimation for confirmatory two-stage flexible multi-arm trial with normal outcomes
- Sample size reassessment in adaptive clinical trials using a bias corrected estimate
- An overview of statistical approaches for adaptive designs and design modifications
- A brief review on software developments for group sequential and adaptive designs
- Sample size re-estimation in clinical trials
- Sample size increase during a survival trial when interim results are promising
- On adaptive extensions of group sequential trials for clinical investigations
- On group sequential procedures under variance heterogeneity
- p-Value calculation for multi-stage additive tests
- Monitoring Continuous Long-Term Outcomes in Adaptive Designs
- Adaptive and nonadaptive group sequential tests
- A sample size adjustment procedure for clinical trials based on conditional power
- Adaptive Design and Estimation in Randomized Clinical Trials with Correlated Observations
- Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers
- Adaptive enrichment designs with a continuous biomarker
- Discussion on “Adaptive enrichment designs with a continuous biomarker” by N. Stallard
- Design aspects of COVID‐19 treatment trials: Improving probability and time of favorable events
- Optimization of adaptive designs with respect to a performance score
- Improving adaptive seamless designs through Bayesian optimization
- Exact change point detection with improved power in small‐sample binomial sequences
- Blinded sample size recalculation in multiple composite population designs with normal data and baseline adjustments
- A two-stage group-sequential design for delayed treatment responses with the possibility of trial restart
- Two-stage randomized clinical trials with a right-censored endpoint: comparison of frequentist and Bayesian adaptive designs
- Adding experimental treatment arms to multi-arm multi-stage platform trials in progress
- Point estimation, confidence intervals, and P-values for optimal adaptive two-stage designs with normal endpoints
- Sample size adaptation designs and efficiency comparison with group sequential designs
- A conditional error function approach for adaptive enrichment designs with continuous endpoints
- A variational approach to optimal two-stage designs
- On the efficiency of adaptive sample size design
- Comments on ``Adaptive sample size modification in clinical trials: start small then ask for more?
- A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation
- Adaptive multiarm multistage clinical trials
- Adaptive enrichment trials: what are the benefits?
- Optimal planning of adaptive two-stage designs
- Statistical tests for two-stage adaptive seamless design using short- and long-term binary outcomes
- Point estimation for adaptive trial designs. I: A methodological review
- New results on optimal conditional error functions for adaptive two-stage designs
- Adaptive seamless phase II/III randomization test considering treatment group selection based on short-term binary outcomes
- Combined p-value functions for compatible effect estimation and hypothesis testing in drug regulation
- Optimality considerations in two-stage biomarker-stratified trials with adaptive enrichment
- Flexible selection of a single treatment incorporating short-term endpoint information in a phase II/III clinical trial
- Two-stage designs for cross-over bioequivalence trials
- Efficient testing of the biomarker positive and negative subgroups in a biomarker-stratified trial
- Adaptive weight selection for time-to-event data under non-proportional hazards
- Connections between permutation and t-tests: relevance to adaptive methods
- Optimizing the data combination rule for seamless phase II/III clinical trials
- Flexible sequential designs for multi-arm clinical trials
- Group sequential designs with prospectively planned rules for subpopulation enrichment
- Optimal flexible sample size design with robust power
This page was built for publication: Adaptive Sample Size Calculations in Group Sequential Trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4668352)
